High tuberculosis burden among HIV-infected populations in Thailand due to a low-sensitivity tuberculin skin test

J Infect Public Health. 2020 Apr;13(4):657-660. doi: 10.1016/j.jiph.2019.08.010. Epub 2019 Sep 26.

Abstract

The current Thai guideline recommends that among people living with HIV, isoniazid preventive therapy (IPT) should be given to those with a positive tuberculin skin test (TST). We conducted a case-control study, nested within a cohort study, in Chiang Rai Province in Thailand to determine the role of TST in predicting the development of active tuberculosis (TB) within the following 2 years. Comparison between participants with CD4+ counts <50cells/mm3 to those with CD4+ ≥200cells/mm3 revealed that TST results were less sensitive (7.7% vs 50.0%) and had a lower negative predictive value (73.1% vs 97.3%) in those with a CD4+ count <50cells/mm3. In people with HIV, using a positive TST result as a criterion for initiating IPT inadvertently decreases the benefits of IPT, especially among those with low CD4+ counts.

Keywords: HIV infection; Isoniazid preventive therapy; Latent tuberculosis infection; Tuberculin skin test; Tuberculosis; Tuberculosis-HIV coinfection.

MeSH terms

  • Adult
  • CD4 Lymphocyte Count
  • Case-Control Studies
  • Coinfection / epidemiology*
  • Coinfection / microbiology
  • Coinfection / virology
  • Cost of Illness
  • False Negative Reactions
  • Female
  • HIV Infections / complications*
  • HIV Infections / epidemiology
  • Humans
  • Male
  • Risk Factors
  • Sensitivity and Specificity
  • Thailand / epidemiology
  • Tuberculin Test* / adverse effects
  • Tuberculosis, Pulmonary / complications
  • Tuberculosis, Pulmonary / diagnosis
  • Tuberculosis, Pulmonary / epidemiology*